These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1451728)

  • 1. Pharmacokinetics of pirmenol in young and elderly subjects.
    Ferry DG; Campbell AJ; Bland R; Beasley M; Gazeley L; Edwards IR
    Eur J Clin Pharmacol; 1992; 43(4):437-9. PubMed ID: 1451728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced pirmenol elimination by rifampin.
    Stringer KA; Cetnarowski AB; Goldfarb A; Lebsack ME; Chang T; Sedman AJ
    J Clin Pharmacol; 1988 Dec; 28(12):1094-7. PubMed ID: 3243925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of oral pirmenol.
    Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
    Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractions.
    Janiczek N; Smith DE; Chang T; Sedman AJ; Stringer KA
    J Clin Pharmacol; 1997 Jun; 37(6):502-13. PubMed ID: 9208357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects and pharmacokinetics of a single oral dose of pirmenol hydrochloride.
    Atarashi H; Kuruma A; Ino T; Hirayama Y; Saitoh H; Hayakawa H
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):556-62. PubMed ID: 8847873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
    Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
    J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of pirmenol enantiomers in coronary artery ligated dogs.
    Janiczek N; Smith DE; Chang T; Ventura A; Mertz TE
    J Pharm Sci; 1997 Apr; 86(4):443-9. PubMed ID: 9109046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical pharmacokinetics of pirmenol.
    Chang T
    Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cimetidine administration on the pharmacokinetics of pirmenol.
    Stringer KA; Lebsack ME; Cetnarowski-Cropp AB; Goldfarb AL; Radulovic LL; Bockbrader HN; Chang T; Sedman AJ
    J Clin Pharmacol; 1992 Jan; 32(1):91-4. PubMed ID: 1740542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
    Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ
    Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective high-performance liquid chromatographic assay for pirmenol enantiomers in dog plasma.
    Janiczek N; Bockbrader HN; Chang T; Amidon GL; Smith DE
    J Chromatogr; 1991 Nov; 571(1-2):179-87. PubMed ID: 1810946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects.
    Ohnishi A; Mihara M; Kamakura H; Tomono Y; Hasegawa J; Yamazaki K; Morishita N; Tanaka T
    J Clin Pharmacol; 1993 Nov; 33(11):1086-91. PubMed ID: 8300891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pirmenol administration on the anti-coagulant activity of warfarin.
    Stringer KA; Switzer DF; Abadier R; Lebsack ME; Sedman A; Chrymko M
    J Clin Pharmacol; 1991 Jul; 31(7):607-10. PubMed ID: 1894756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
    Johnson BF; Haffajee CI; Woodman T; Sloan KL
    J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pirmenol on premature atrial complexes.
    Toivonen LK
    Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
    de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide pharmacokinetics in healthy young adult and elderly subjects.
    Hatorp V; Huang WC; Strange P
    Clin Ther; 1999 Apr; 21(4):702-10. PubMed ID: 10363735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic monitoring of class I antiarrhythmic agents using high-resolution electrocardiography instead of blood samples.
    Sutovsky I; Katoh T; Takayama H; Ono T; Takano T
    Circ J; 2003 Mar; 67(3):195-8. PubMed ID: 12604865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.